                         SEQUENCE LISTING

<110>  LAWRENCE LIVERMORE NATIONAL SECURITY, LLC
 
<120>  SYNTHETIC APOLIPOPROTEINS, AND RELATED COMPOSITIONS METHODS AND 
       SYSTEMS FOR NANOLIPOPROTEIN PARTICLES FORMATION

<130>  IL-12402

<150>  62/217,316
<151>  2015-09-11

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  1

Gln Arg Trp Glu Leu Ala Leu Gly Arg Phe Trp Asp Tyr Leu Arg Trp 
1               5                   10                  15      


Val Gln Thr Leu Ser Glu Gln Val Gln Glu Glu Leu Leu 
            20                  25                  


<210>  2
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  2

Ser Gln Val Thr Gln Glu Leu Arg Ala Leu Met Asp Glu Thr Met Lys 
1               5                   10                  15      


Glu Leu Lys Ala Tyr Lys Ser Glu Leu Glu Glu Gln Leu 
            20                  25                  


<210>  3
<211>  42
<212>  PRT
<213>  Homo sapiens

<400>  3

Ala Glu Glu Thr Arg Ala Arg Leu Ser Lys Glu Leu Gln Ala Ala Gln 
1               5                   10                  15      


Ala Arg Leu Gly Ala Asp Met Glu Asp Val Arg Gly Arg Leu Val Gln 
            20                  25                  30          


Tyr Arg Gly Glu Val Gln Ala Met Leu Gly 
        35                  40          


<210>  4
<211>  37
<212>  PRT
<213>  Homo sapiens

<400>  4

Ser Thr Glu Glu Leu Arg Val Arg Leu Ala Ser His Leu Arg Lys Leu 
1               5                   10                  15      


Arg Lys Arg Leu Leu Arg Asp Ala Asp Asp Leu Gln Lys Arg Leu Ala 
            20                  25                  30          


Val Tyr Gln Ala Gly 
        35          


<210>  5
<211>  29
<212>  PRT
<213>  Synthetic Peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (26)..(26)
<223>  X is 2-Aminoisobutyric acid

<400>  5

Gln Arg Trp Glu Leu Xaa Leu Gly Arg Phe Trp Xaa Tyr Leu Arg Trp 
1               5                   10                  15      


Xaa Gln Thr Leu Ser Xaa Gln Val Gln Xaa Glu Leu Leu 
            20                  25                  


<210>  6
<211>  29
<212>  PRT
<213>  Synthetic Peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  X is 2-Aminoisobutyric acid

<400>  6

Ser Gln Xaa Thr Gln Glu Leu Arg Xaa Leu Met Asp Glu Xaa Met Lys 
1               5                   10                  15      


Glu Leu Lys Xaa Tyr Lys Ser Glu Xaa Glu Glu Gln Leu 
            20                  25                  


<210>  7
<211>  42
<212>  PRT
<213>  Synthetic Peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (26)..(26)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  X is 2-Aminoisobutyric acid

<400>  7

Ala Glu Glu Thr Arg Xaa Arg Leu Ser Lys Glu Leu Gln Xaa Ala Gln 
1               5                   10                  15      


Ala Arg Leu Gly Xaa Asp Met Glu Asp Xaa Arg Gly Arg Leu Val Gln 
            20                  25                  30          


Tyr Arg Xaa Glu Val Gln Ala Met Leu Gly 
        35                  40          


<210>  8
<211>  37
<212>  PRT
<213>  Synthetic Peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (32)..(32)
<223>  X is 2-Aminoisobutyric acid

<400>  8

Ser Thr Glu Glu Xaa Arg Val Arg Leu Xaa Ser His Leu Arg Lys Leu 
1               5                   10                  15      


Arg Lys Arg Leu Leu Arg Asp Xaa Asp Asp Leu Gln Lys Arg Leu Xaa 
            20                  25                  30          


Val Tyr Gln Ala Gly 
        35          


<210>  9
<211>  43
<212>  PRT
<213>  Bombyx mori

<400>  9

Lys Val Ser Ser Asn Val Gln Glu Thr Asn Glu Lys Leu Ala Pro Lys 
1               5                   10                  15      


Ile Lys Ala Ala Tyr Asp Asp Phe Ala Lys Asn Thr Gln Glu Val Ile 
            20                  25                  30          


Lys Lys Ile Gln Glu Ala Ala Asn Ala Lys Gln 
        35                  40              


<210>  10
<211>  44
<212>  PRT
<213>  Synthetic Peptide


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  X is 2-Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  X is 2-Aminoisobutyric acid

<400>  10

Lys Val Ser Ser Asn Val Gln Glu Thr Asn Xaa Lys Leu Ala Pro Lys 
1               5                   10                  15      


Lys Ile Lys Ala Xaa Tyr Asp Asp Phe Ala Lys Asn Thr Gln Xaa Val 
            20                  25                  30          


Ile Lys Lys Ile Gln Glu Xaa Ala Asn Ala Lys Gln 
        35                  40                  


<210>  11
<211>  164
<212>  PRT
<213>  Homo sapiens

<400>  11

Lys Val Glu Gln Ala Val Glu Thr Glu Pro Glu Pro Glu Leu Arg Gln 
1               5                   10                  15      


Gln Thr Glu Trp Gln Ser Gly Gln Arg Trp Glu Leu Ala Leu Gly Arg 
            20                  25                  30          


Phe Trp Asp Tyr Leu Arg Trp Val Gln Thr Ser Glu Gln Val Gln Glu 
        35                  40                  45              


Glu Leu Leu Ser Ser Gln Val Thr Gln Glu Leu Arg Ala Leu Met Asp 
    50                  55                  60                  


Glu Thr Met Lys Glu Leu Lys Ala Tyr Lys Ser Glu Leu Glu Glu Gln 
65                  70                  75                  80  


Leu Thr Pro Val Ala Glu Glu Thr Arg Ala Arg Leu Ser Lys Glu Leu 
                85                  90                  95      


Gln Ala Ala Gln Ala Arg Leu Gly Ala Asp Met Glu Asp Val Arg Gly 
            100                 105                 110         


Arg Leu Val Gln Tyr Arg Gly Glu Val Gln Ala Met Leu Gly Gln Ser 
        115                 120                 125             


Thr Glu Glu Leu Arg Val Arg Leu Ala Ser His Leu Arg Lys Leu Arg 
    130                 135                 140                 


Lys Arg Leu Leu Arg Asp Ala Asp Asp Leu Gln Lys Arg Leu Ala Val 
145                 150                 155                 160 


Tyr Gln Ala Gly 
                


